377 filings
Page 13 of 19
6-K
2n78pql
27 Jun 16
GW Pharmaceuticals Announces Positive Phase 3 Pivotal Trial Results for Epidiolex® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome
12:00am
6-K
fdb3f6wx xldcp
21 Jun 16
Current report (foreign)
12:00am
CT ORDER
ik9sxhd0pm619 k4hn
16 Jun 16
Confidential treatment order
12:00am
6-K
ssl82
13 May 16
Current report (foreign)
12:00am
6-K
9oq7m6zq5q8vf7
5 May 16
GW Pharmaceuticals plc Reports Second Quarter and Half-Year 2016 Financial Results and Operational Progress
12:00am
6-K
hrclin ljevs1zl03tso
25 Apr 16
GW Pharmaceuticals Receives Orphan Drug Designation from FDA for Cannabidiol for the Treatment of Tuberous Sclerosis Complex
12:00am
6-K
i7lwpyoqfy9hhdj8jqzl
11 Apr 16
Current report (foreign)
12:00am
6-K
2hrikcg
1 Apr 16
Current report (foreign)
12:00am
6-K
2bzjp4
14 Mar 16
Current report (foreign)
12:00am
6-K
n2w2fygqp
19 Feb 16
Current report (foreign)
12:00am
SC 13G/A
4zsuyrf
16 Feb 16
GW Pharmaceuticals PLC
12:00am
SC 13G/A
zxozbg 7cqb1
16 Feb 16
GW Pharmaceuticals PLC
12:00am
SC 13G/A
j8g42 rddajx4pbn
12 Feb 16
GW Pharmaceuticals PLC
12:00am
SC 13G/A
a5buqlbqpn
11 Feb 16
Beneficial ownership report (amended)
12:00am
6-K
vabmmk97c9uf3ojjt3
10 Feb 16
GW Pharmaceuticals plc Reports First Quarter 2016 Financial Results and Operational Progress
12:00am
6-K
smzjuv83d
29 Dec 15
Current report (foreign)
12:00am
6-K
4mk805i49uwk2t
28 Dec 15
Current report (foreign)
12:00am
6-K
49cl2utrr59mpa7g81yg
22 Dec 15
Current report (foreign)
12:00am
6-K
uljyitcqglz 0v68g
7 Dec 15
GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2015 Financial Results and Operational Progress
12:00am